Literature DB >> 12376919

Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites.

Vesna Jurcić1, Andreja Zidar, Maria Delia Perez Montiel, Snjezana Frković-Grazio, Simon J Nayler, Kumarasen Cooper, Saul Suster, Janez Lamovec.   

Abstract

We report on nine new cases of myxoinflammatory fibroblastic sarcoma; in six of them the location of the tumor was distal (acral), and proximal in three (forearm, arm, and thigh). Tumors varied in size from 1.5 to 18 cm, were well-circumscribed, yellow-tan, and focally myxomatous. Histologically, they were similar in appearance and showed vaguely lobular architecture and oval, spindle, and epithelioid neoplastic cells with scattered, focally aggregated inflammatory cells. In all cases, in different numbers, bizarre giant cells with large, lobulated, or multiple nuclei were also admixed, some of them morphologically imitating Reed-Sternberg cells, lipoblasts, or ganglion cells; they showed distinct nucleoli or intranuclear inclusions. Myxoid areas were always present, to different extent. Immunohistochemically, tumor cells were uniformly positive for vimentin; some cells were also positive for CD68 and CD34. Ultrastructurally, tumor cells were nondescript, consistent with fibroblastic origin. On flow cytometry, two of the examined cases showed diploid pattern with low S-phase fraction. In none of the cases, metastases were observed, in one case the tumor recurred 5 years following surgery. We conclude that myxoinflammatory fibroblastic sarcoma is a distinct soft tissue tumor of low-grade malignancy and, until now, described only in extremities, although not confined to acral sites. Copyright 2002, Elsevier Science (USA)

Entities:  

Mesh:

Year:  2002        PMID: 12376919     DOI: 10.1053/adpa.2002.35738

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  11 in total

Review 1.  Myxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature.

Authors:  Daniel Baumhoer; Kathrin Glatz; Hans-Jürgen Schulten; László Füzesi; Renato Fricker; Christoph Kettelhack; Paula Hasenboehler; Martin Oberholzer; Gernot Jundt
Journal:  Virchows Arch       Date:  2007-08-11       Impact factor: 4.064

2.  Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.

Authors:  William B Laskin; John F Fetsch; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

Review 3.  A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases.

Authors:  Raffaele Lombardi; Elio Jovine; Nicola Zanini; Maria Cristina Salone; Marco Gambarotti; Alberto Righi; Alba Balladelli; Marco Colangeli; Michele Rocca
Journal:  Int Orthop       Date:  2013-09-06       Impact factor: 3.075

4.  Acral myxoinflammatory fibroblastic sarcoma: A case report and literature review.

Authors:  Andrew G Silver; Richard C Baynosa; Raman C Mahabir; Wei Z Wang; William A Zamboni; Kayvan T Khiabani
Journal:  Can J Plast Surg       Date:  2013

5.  A rare case of acral myxoinflammatory fibroblastic sarcoma at the hand.

Authors:  Andrea Leti Acciaro; Roberto Gabrieli; Antonio Landi
Journal:  Musculoskelet Surg       Date:  2010-01-12

6.  Myxoinflammatory fibroblastic sarcoma: an uncommon tumour at an unusual site.

Authors:  Varuna Mallya; Avninder Singh; Fouzia Siraj; V Ramesh
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

7.  Myxoinflammatory Fibroblastic Sarcoma: A Radiographical, Pathological, and Immunohistochemical Report of Rare Malignancy.

Authors:  Michitaka Kato; Takuji Tanaka; Takatoshi Ohno
Journal:  Case Rep Orthop       Date:  2015-05-18

8.  Large cervicothoracic myxoinflammatory fibroblastic sarcoma with brachial plexus invasion: A case report and literature review.

Authors:  Xiaotian Jia; Jianyun Yang; Lin Chen; Cong Yu
Journal:  Oncol Lett       Date:  2016-07-08       Impact factor: 2.967

9.  Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.

Authors:  David Suster; Michael Michal; Huiya Huang; Shira Ronen; Stephanie Springborn; Maria Debiec-Rychter; Steven D Billings; John R Goldblum; Brian P Rubin; Michal Michal; Saul Suster; A Craig Mackinnon
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

10.  Giant myxoinflammatory fibroblastic sarcoma with bone invasion: a very rare clinical entity and literature review.

Authors:  Guray Togral; Murat Arikan; Elif Aktas; Safak Gungor
Journal:  Chin J Cancer       Date:  2014-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.